PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

✍ Scribed by P.L. Zinzani; J.M. Connors; A.D. Knight; A.M. Crowe; R. Jones; B. Tucker

• Book ID: 119309136
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 59 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.02.355